China Extracorporeal Life Support Registry
Recruiting
Observational Study
Cardiogenic Shock
Cardiac Arrest
Heart Failure
Acute Respiratory Distress Syndrome
Acute Respiratory Failure
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 20,000 (estimated)
- Sponsor
- Beijing Anzhen Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Extracorporeal life support (ECLS), also known as extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective cardiac and respiratory support to patients with lungs and/or heart failure. There was a growth in ECLS cases, centers, and center scale in China during the past decade.
This multi-center registry was conducted by Chinese Society of Extracorporeal Lif…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients receiving ECMO for circulatory and/or respiratory support
Exclusion Criteria:
* Refusal of consent
Contacts